Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression

  • STATUS
    Recruiting
  • End date
    Jun 27, 2024
  • participants needed
    90
  • sponsor
    Tanta University
Updated on 27 May 2022

Summary

This randomized controlled trial aims at evaluating the efficacy and safety of the antidiabetics metformin versus empagliflozin on chronic kidney disease (CKD) progression in patients with CKD stages 2 or/and 3.

Details
Condition Renal Insufficiency, Chronic
Treatment Metformin, Empagliflozin, Standard therapy
Clinical Study IdentifierNCT05373680
SponsorTanta University
Last Modified on27 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with mild or/and moderate chronic kidney disease (stages 2 or/and 3, estimated glomerular filtration rate (eGFR) between 30-89 ml/min/1.73 m2) at the time of the baseline visit
Patients with and without type 2 diabetes
Patients with or without proteinuria
Age: ≥ 18 years

Exclusion Criteria

Type 1 diabetes
Patients with eGFR ˂30 ml/min/1.73 m2
Patients with known hepatic cell failure
Decompensated heart requiring acute management
Active malignancy
Planned coronary or surgical interventions
Known hypersensitivity to study medications
Chronic inflammation, trauma, or infection
Pregnant or lactating women
Patients already on metformin or a sodium-glucose cotransporter-2 (SGLT2) inhibitor
Any of the study treatments labeled contraindications
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note